Need a specific person's email?
Browse BioPharm Communications's employee directory (about 100 employees) and reveal verified emails free.
BioPharm Communications's most common email format is FLast@biopharmcommunications.com (ex. JDoe@biopharmcommunications.com), used for 78% of biopharmcommunications.com addresses. BioPharm Communications uses 4 email patterns.
| Format | Example | Share of biopharmcommunications.com |
|---|---|---|
| FLast@biopharmcommunications.comMost common | JDoe@biopharmcommunications.com | |
| First.Last@biopharmcommunications.com | John.Doe@biopharmcommunications.com | |
| Last@biopharmcommunications.com | Doe@biopharmcommunications.com | |
| FMLast@biopharmcommunications.com | JMDoe@biopharmcommunications.com |
Browse BioPharm Communications's employee directory (about 100 employees) and reveal verified emails free.
Advertising ServicesPennsylvania, United States51-200 Employees
BioPharm Communications operates in the advertising services sector with a focus on healthcare. The company is based in New Hope, Pennsylvania, and traces its founding to 2005, giving it about two decades of industry experience. It maintains an Always ON network reaching more than 3 million healthcare decision makers, enabling multichannel outreach to healthcare professionals and decision makers. Its service approach centers on developing omnichannel strategies and guiding clients through end-to-end media journeys, supported by data-driven campaign execution. The firm targets biopharma companies and related healthcare brands, addressing the challenge of connecting with clinicians and other decision makers across channels. In 2019, BioPharm Communications published an E-Book on HCP multichannel marketing, reflecting engagement with industry topics beyond client work.
Most common format
FLast@biopharmcommunications.com
Example: JDoe@biopharmcommunications.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.